These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16420518)

  • 1. Effect of celecoxib on experimental liver fibrosis in rat.
    Hui AY; Leung WK; Chan HL; Chan FK; Go MY; Chan KK; Tang BD; Chu ES; Sung JJ
    Liver Int; 2006 Feb; 26(1):125-36. PubMed ID: 16420518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes.
    Wen SL; Gao JH; Yang WJ; Lu YY; Tong H; Huang ZY; Liu ZX; Tang CW
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1932-42. PubMed ID: 24909904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat.
    Chávez E; Segovia J; Shibayama M; Tsutsumi V; Vergara P; Castro-Sánchez L; Salazar EP; Moreno MG; Muriel P
    Liver Int; 2010 Aug; 30(7):969-78. PubMed ID: 20524983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.
    Planagumà A; Clària J; Miquel R; López-Parra M; Titos E; Masferrer JL; Arroyo V; Rodés J
    FASEB J; 2005 Jul; 19(9):1120-2. PubMed ID: 15876570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis.
    Vardar-Sengul S; Buduneli E; Turkoglu O; Buduneli N; Atilla G; Wahlgren J; Sorsa T; Baylas H
    J Periodontol; 2008 Oct; 79(10):1934-41. PubMed ID: 18834249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.
    Tu CT; Guo JS; Wang M; Wang JY
    J Gastroenterol Hepatol; 2007 Jun; 22(6):877-84. PubMed ID: 17565644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
    Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
    Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats.
    George J; Tsutsumi M
    Gene Ther; 2007 May; 14(10):790-803. PubMed ID: 17344905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of interferon-α on rat liver fibrosis induced by CCl(4)].
    Li Y; Yang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):243-8. PubMed ID: 21464546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
    Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
    Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver.
    Kapoor S; Bahde R
    Liver Int; 2009 Aug; 29(7):1125; author reply 1125-6. PubMed ID: 19508621
    [No Abstract]   [Full Text] [Related]  

  • 12. Celecoxib exacerbates hepatic fibrosis and induces hepatocellular necrosis in rats treated with porcine serum.
    Liu H; Wei W; Li X
    Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):63-7. PubMed ID: 19007904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
    Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
    Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB; Li DG; Lu HM
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress.
    Su SC; Tanimoto K; Tanne Y; Kunimatsu R; Hirose N; Mitsuyoshi T; Okamoto Y; Tanne K
    Osteoarthritis Cartilage; 2014 Jun; 22(6):845-51. PubMed ID: 24721459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats.
    Ekor M; Odewabi AO; Kale OE; Adesanoye OA; Bamidele TO
    Drug Chem Toxicol; 2013 Jan; 36(1):1-8. PubMed ID: 22168377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporative alpha-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation.
    Wang CH; Lee TH; Lu CN; Chou WY; Hung KS; Concejero AM; Jawan B
    Gene Ther; 2006 Jul; 13(13):1000-9. PubMed ID: 16511523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury.
    Harris TR; Kodani S; Rand AA; Yang J; Imai DM; Hwang SH; Hammock BD
    Mol Pharmacol; 2018 Aug; 94(2):834-841. PubMed ID: 29844231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation.
    Chou WY; Lu CN; Lee TH; Wu CL; Hung KS; Concejero AM; Jawan B; Wang CH
    Acta Pharmacol Sin; 2006 Apr; 27(4):469-76. PubMed ID: 16539848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
    Tian F; Zhang YJ; Li Y; Xie Y
    PLoS One; 2014; 9(1):e83819. PubMed ID: 24404139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.